Abstract:Background: While the phenotypic association between anti-Müllerian hormoneand age at menopause has been widely studied, the role of anti-Müllerian hormone in predicting the age at menopause is currently controversial, and the genetic architecture or causal relationships underlying these 2 traits is not well understood. Aim: We aimed to explore the shared genetic architecture between anti-Müllerian hormone and age at menopause, to identify shared pleiotropic loci and genes, and to investigate causal association and potential causal mediators. Study design: Using summary statistics from publicly available genome-wide association studies on anti-Müllerian hormone (N=7049) and age at menopause (N=201,323) in Europeans, we investigated the global genetic architecture between anti-Müllerian hormone and age at menopause through linkage disequilibrium score regression. We employed pleiotropic analysis under composite null hypothesis, Functional Mapping and Annotation of Genetic Associations, multimarker analysis of GenoMic annotation, and colocalization analysis to identify loci and genes with pleiotropic effects. Tissue enrichment analysis based on Genotype-Tissue Expression data was conducted using the Linkage Disequilibrium Score for the specific expression of genes analysis. Functional genes that were shared were additionally identified through summary data-based Mendelian randomization. The relationship between anti-Müllerian hormone and age at menopause was examined through 2-sample Mendelian randomization, and potential mediators were further explored using colocalization and metabolite-mediated analysis. Results: A positive genetic association (correlation coefficient=0.88, P=1.33×10-5) was observed between anti-Müllerian hormone and age at menopause. By using pleiotropic analysis under composite null hypothesis and Functional Mapping and Annotation of Genetic Associations, 42 significant pleiotropic loci were identified that were associated with anti-Müllerian hormone and age at menopause, and 10 of these (rs10734411, rs61913600, rs2277339, rs75770066, rs28416520, rs9796, rs11668344, rs403727, rs6011452, and rs62237617) had colocalized loci. Additionally, 245 significant pleiotropic genes were identified by multimarker analysis of GenoMic annotation. Genetic associations between anti-Müllerian hormone and age at menopause were markedly concentrated in various tissues including whole blood, brain, heart, liver, muscle, pancreas, and kidneys. Further, summary data-based Mendelian randomization analysis revealed 9 genes that may have a causative effect on both anti-Müllerian hormone and age at menopause. A potential causal effect of age at menopause on anti-Müllerian hormone was suggested by 2-sample Mendelian randomization analysis, with very-low-density lipoprotein identified as a potential mediator. Conclusion: Our study revealed a shared genetic architecture between anti-Müllerian hormone and age at menopause, providing a basis for experimental investigations and individual therapies to enhance reproductive outcomes. Furthermore, our findings emphasized that relying solely on anti-Müllerian hormone is not sufficient for accurately predicting the age at menopause, and a combination of other factors needs to be considered. Exploring new therapeutics aimed at delaying at the onset of menopause holds promise, particularly when targeting shared genes based on their shared genetic architecture.

A Review of Molecular Mechanisms, Age Inference, and Implications for Men's Health

The impact of mosaic loss of the Y chromosome (mLOY) in men of advanced age

Mosaic loss of the Y chromosome in human neurodegenerative and oncological diseases

Mosaic loss of Y chromosome and the association to mortality in Danish men aged 56-100 years

Mosaic Loss of Human Y Chromosome: What, How and Why

A complex systems approach to mosaic loss of the Y chromosome

Loss of chromosome Y (LOY) in blood cells is associated with increased risk for disease and mortality in aging men

Loss of Y chromosome: An emerging next-generation biomarker for disease prediction and early detection?

Y Chromosome Loss and Implications for Oncology

Mosaic loss of chromosome Y in peripheral blood cells is associated with age-related macular degeneration in men

Why Y matters? The implication of loss of Y chromosome in blood and cancer

Circulating macrophages as the mechanistic link between mosaic loss of Y-chromosome and cardiac disease

Abstract 3430: Mosaic loss of the Y chromosome is associated with prostate cancer risk

Genomic and phenotypic correlates of mosaic loss of chromosome Y in blood

Dissecting the shared genetic architecture between anti-Müllerian hormone and age at menopause based on genome-wide association study

Particulate matter pollution, polygenic risk score and mosaic loss of chromosome Y in middle-aged and older men from the Dongfeng-Tongji cohort study

[Epidemiological Distribution of Mosaic Loss of Chromosome Y in Adult Men in 10 Areas in China and Its Prospective Association with Lung Cancer].

Testicular aging, male fertility and beyond

Consequences of Y chromosome microdeletions beyond male infertility

MosCoverY: a new method to estimate mosaic Loss of Y chromosome from NGS sequencing coverage data

Age‐dependent DNA methylation patterns on the Y chromosome in elderly males